SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: xomadog2 who wrote (9465)3/31/1999 8:44:00 AM
From: Robert K.  Read Replies (3) | Respond to of 17367
 
I basically agree with xomadog on this on, but please lets not get into a shouting match over little stuff. You are both right.
George>build it and they will come.(my words)
Xomadog>our words change nothing,what will be will be, let them do their jobs.
btw-that meningo patent will fit nicely into a meningo news item.



To: xomadog2 who wrote (9465)3/31/1999 9:52:00 AM
From: aknahow  Respond to of 17367
 
Ask yourself why you think XOMA is a 50% partner?

Ask yourself why you think it is not an open question as to who will manage P III?

Why do think any payment will be due XOMA should GNE decide to continue on alone?

Have you ever heard of doing a dosing P I trial after the P II is complete?

Have you no interest in why this is necessary?

XOMA is owned by its' shareholders. Do you feel, that you as a shareholder have a right to be kept informed?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News